Pressemappe: Eli Lilly and Company
Aktuelle Aussendungen (30 Treffer in 60 Monaten)
Nächste Seite
Lilly Global gibt Mitarbeitern mehr Möglichkeiten zu gemeinnütziger Arbeit =
OTS0002 / 26.07.2011 / 01:59:03 / Channel: Wirtschaft / Aussender: Eli Lilly and Company
Lilly CEO Says Industry, Public Policy Must Pave Way For Innovation =
OTE0005 / 10.02.2011 / 10:17:33 / Channel: Wirtschaft / Aussender: Eli Lilly and Company
Mortality Data Presented for Patients Treated with Efient(R)/Effient(R) (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery =
OTE0007 / 16.11.2010 / 16:03:03 / Channel: Wirtschaft / Aussender: Eli Lilly and Company
Lilly Halts Development of Semagacestat for Alzheimer's Disease Based on Preliminary Results of Phase III Clinical Trials =
OTE0006 / 17.08.2010 / 14:01:36 / Channel: Wirtschaft / Aussender: Eli Lilly and Company
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor =
OTE0006 / 13.11.2009 / 15:11:41 / Channel: Wirtschaft / Aussender: Eli Lilly and Company
Eight out of 10 People Diagnosed With Heart Disease Consider Their Diagnosis a 'Wake-Up Call' =
OTE0012 / 31.08.2009 / 16:37:04 / Channel: Wirtschaft / Aussender: Eli Lilly and Company
World Heart Federation, Daiichi Sankyo and Lilly Partner to Improve Cardiovascular Health =
OTE0002 / 31.03.2009 / 06:07:36 / Channel: Wirtschaft / Aussender: Eli Lilly and Company
Duloxetine Significantly Reduced Osteoarthritis Knee Pain in New Study =
OTE0013 / 30.01.2009 / 12:07:13 / Channel: Wirtschaft / Aussender: Eli Lilly and Company
New Data Show Duloxetine Maintained Pain Reduction for More Than Six Months in Patients With Diabetic Peripheral Neuropathic Pain =
OTE0012 / 19.08.2008 / 16:20:35 / Channel: Wirtschaft / Aussender: Eli Lilly and Company
Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease =
OTE0007 / 30.07.2008 / 22:22:37 / Channel: Wirtschaft / Aussender: Eli Lilly and Company
Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease =
OTE0008 / 31.03.2008 / 10:04:09 / Channel: Wirtschaft / Aussender: Eli Lilly and Company
Lilly gibt Weltgesundheitsorganisation 4,4 Mio. US-Dollar für Ausbau von MDR-TB-Programm =
OTS0055 / 12.03.2008 / 09:08:12 / Channel: Wirtschaft / Aussender: Eli Lilly and Company
FORSTEO(R) erhält positive Einschätzung des Europäischen Ausschusses für Humanarzneimittel (CHMP) zur Behandlung von glukokortikoidinduzierter Osteoporose =
OTS0001 / 23.02.2008 / 00:02:04 / Channel: Wirtschaft / Aussender: Eli Lilly and Company
Global 'Inspired by Diabetes' Creative Expression Competition Deadline Extended Until March 31, 2008 =
OTE0011 / 05.02.2008 / 22:59:08 / Channel: Wirtschaft / Aussender: Eli Lilly and Company
Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel =
OTE0002 / 04.11.2007 / 14:09:42 / Channel: Wirtschaft / Aussender: Eli Lilly and Company
